Upcoming webinars
Oct 28, 202610:30 AM ET
The evolution of MRD: From molecular detection to clinical decisions
sponsored by Abbott
Nov 3, 202611:30 AM ET
Trust, not autonomy: Deploying agentic AI in GxP environments
sponsored by Katalyze
Nov 4, 202611:00 AM ET
Cutting through the noise: How biopharma is actually using AI to scale oncology research
sponsored by Flatiron Health
Nov 12, 202612:30 PM ET
From data to diagnostic: How AI is powering biomarker discovery
sponsored by Guardant Health
Nov 19, 202612:30 PM ET
Is your drug working? Earlier insights with molecular response monitoring and RWD
sponsored by Natera
Interested in hosting a webinar?
Whether your goal is brand building, thought leadership or generating leads, we can help you reach your target market with a high-quality production.
Recent webinars
Oct 22, 2026
A new model for clinical research – Expanding community trial access
sponsored by Parexel
Oct 15, 2026
Insights into polycystic kidney disease: The potential of clinicogenomic data
sponsored by Natera
Sep 16, 2026
Beyond ICD codes: Unlocking rare disease insights with genomics and claims-based data
sponsored by GeneDx
All past webinars
| Action | |||
|---|---|---|---|
Inside the IDMO model: Analytical comparability, regulatory readiness and operational excellence | Sep 10, 2026 | Cellares | Watch now |
How leading pharma organizations are putting AI agents to work | Sep 3, 2026 | Medable | Watch now |
Same molecule, different paths: Where value goes in cross-border dealmaking in a new era | Aug 27, 2026 | PharmCube | Watch now |
From pilots to production: AI across R&D, safety, regulatory and clinical | Aug 19, 2026 | IBM | Watch now |
Accelerating Phase 1 decisions with liquid biopsy: From early signals to actionable insights | Jul 30, 2026 | Guardant Health | Watch now |
Data-driven manufacturing: Enhancing process robustness across sites | Jun 11, 2026 | Samsung Biologics | Watch now |
From signal to strategy: The future of systemic viral immunotherapy in GI tumors and Oncolytics Biotech | May 28, 2026 | OncolyticsBiotech | Watch now |
Application of Simple Western to analysis of antibody target affinity and specificity | May 20, 2026 | Bio-Techne | Watch now |
The surprising versatility of MGDs: Different ways for Cereblon to engage its targets | May 12, 2026 | Thermo Fisher | Watch now |
The path to self-driving: Leveraging agentic AI to drive the future of clinical drug development | May 5, 2026 | Medable | Watch now |
Inside the IDMO model: Analytical comparability, regulatory readiness and operational excellence
Sep 10, 2026
sponsored by Cellares
Watch nowHow leading pharma organizations are putting AI agents to work
Sep 3, 2026
sponsored by Medable
Watch nowSame molecule, different paths: Where value goes in cross-border dealmaking in a new era
Aug 27, 2026
sponsored by PharmCube
Watch nowFrom pilots to production: AI across R&D, safety, regulatory and clinical
Aug 19, 2026
sponsored by IBM
Watch nowAccelerating Phase 1 decisions with liquid biopsy: From early signals to actionable insights
Jul 30, 2026
sponsored by Guardant Health
Watch nowData-driven manufacturing: Enhancing process robustness across sites
Jun 11, 2026
sponsored by Samsung Biologics
Watch nowFrom signal to strategy: The future of systemic viral immunotherapy in GI tumors and Oncolytics Biotech
May 28, 2026
sponsored by OncolyticsBiotech
Watch nowApplication of Simple Western to analysis of antibody target affinity and specificity
May 20, 2026
sponsored by Bio-Techne
Watch nowThe surprising versatility of MGDs: Different ways for Cereblon to engage its targets
May 12, 2026
sponsored by Thermo Fisher
Watch nowThe path to self-driving: Leveraging agentic AI to drive the future of clinical drug development
May 5, 2026
sponsored by Medable
Watch now